The statistic everyone has heard is that one in three women over 35 won’t conceive after a year of trying. It comes from French birth records covering 1670 to 1830, a population with no modern medicine, no contraception and no way to time intercourse. It’s still being quoted at women in their thirties as though it describes them.
Age does affect fertility. It affects it less abruptly, and less catastrophically, than the way it’s usually communicated.
What actually changes
Two things, and they’re related but distinct.
Quantity. You’re born with your full complement of eggs and the number declines continuously from before birth. The decline steepens somewhat from the late thirties. Anti-Müllerian hormone, or AMH, gives a rough measure of remaining quantity.
Quality. This is the one that matters more for conception and for miscarriage risk. Eggs remain arrested mid-division for decades, and the cellular machinery that separates chromosomes correctly becomes less reliable with time. The result is a rising proportion of eggs with chromosomal abnormalities, which is why both conception rates fall and miscarriage rates rise with age.
The rise in chromosomal abnormality is gradual through the thirties and steeper in the forties. There’s no cliff at 35. That number is a convention for classifying pregnancies as higher-risk, not a biological event.
What AMH does and doesn’t tell you
Worth its own section, because AMH testing is now marketed directly to women and routinely misinterpreted.
AMH estimates how many eggs remain. It says nothing about their quality, which is the variable that actually determines whether a given cycle produces a viable pregnancy.
Studies of women without known fertility problems have found that AMH levels do not predict the chance of conceiving naturally within a year. A low result in a woman with regular cycles is not a reason to panic, and a reassuring result is not a guarantee.
Where AMH is genuinely useful is in predicting response to ovarian stimulation in IVF, which is what it was developed for. Outside that context it generates a great deal of anxiety for limited informational return.
What doesn’t change much
Cycle length often shortens somewhat from the late thirties, mainly through a shorter follicular phase, which means ovulation arrives earlier than it used to. That’s a practical point for anyone still counting from an assumed day 14.
The luteal phase stays fairly stable until perimenopause. Regular ovulatory cycles usually continue into the forties. The fertile window remains about six days long. The signs remain readable.
Which means the method still works. If anything it becomes more valuable, because the calendar assumptions people rely on drift further from reality as cycles shift.
Roughly what to expect
Per-cycle conception rates decline gradually rather than falling off a step. Cumulative rates over twelve months remain substantial through the late thirties for couples with no underlying fertility problem and reasonable timing.
Miscarriage risk rises with maternal age, and most of that increase is attributable to chromosomal abnormality. That’s worth knowing in advance, because it’s the part people are least prepared for.
Time to conception lengthens on average, which is exactly why the guidance on when to seek help changes: twelve months of trying under 35, six months at 35 and over. That shorter threshold isn’t a judgement, it’s an acknowledgement that there’s less margin for waiting.
The half nobody mentions
Paternal age affects outcomes too, with associations between advanced paternal age and reduced sperm quality, longer time to conception, and elevated risk of certain conditions in offspring. It’s discussed a small fraction as often as maternal age. If you’re being asked about your age, it’s reasonable to ask about his.
What’s actually within your control
Timing does more than anything else on this list. Intercourse in the fertile window, identified from your own signs rather than a calendar average, is the single highest-impact change available. A meaningful share of couples described as struggling are mistiming, and that’s more likely in your late thirties precisely because ovulation may have shifted earlier than you assume. Our guide to identifying your fertile window covers it.
Then the ordinary things. Smoking accelerates the loss of ovarian reserve. Weight at either extreme affects ovulation. Folate before conception has strong evidence behind it, as our piece on preconception nutrition sets out. Underlying conditions like thyroid dysfunction, PCOS or endometriosis are worth identifying and treating rather than attributing everything to age.
Egg quality supplements are the growth industry here. Coenzyme Q10 and DHEA are the most promoted, both mostly studied in poor-responder IVF populations with mixed results. Neither is established for general use, and the confidence of the marketing exceeds the evidence considerably.
Seeking help isn’t giving up on the natural approach
Charting and medical investigation aren’t alternatives. A few months of charts is genuinely useful clinical data: it establishes whether you’re ovulating, when, and how long your luteal phase runs, which is more than most initial consultations start with.
At 35 and over, six months of well-timed trying without success is the point to ask for investigation. Early tests are simple and cheap: thyroid function, progesterone timed to your actual ovulation rather than an assumed day 21, and a semen analysis. Finding a treatable problem at 36 is considerably better than finding it at 39.
Time it from your own signs
NaturaPlan in Conceive mode identifies your fertile window from your mucus and temperature, not from an average. Free, no account, everything stays on your device.
This article is for educational purposes and does not constitute medical advice. Seek advice after six months of trying if you’re 35 or over.


